Siti Khadijah Kiraman

Siti Khadijah Kiraman

Auto-generated profile, based on publicly available information

Siti Khadijah Kiraman

Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang Al-Sultan Abdullah, Gambang, Malaysia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SKSiti Khadijah Kiraman
Siti Khadijah Kiraman
IZIzyan Atiqah Zakaria
Izyan Atiqah Zakaria
LELoh Sweet Yi Esther
Loh Sweet Yi Esther
FNFarisha Alia Norfuad
Farisha Alia Norfuad
NGNur Azurah Abdul Ghani
Nur Azurah Abdul Ghani
HAHajar Fauzan Ahmad
Hajar Fauzan Ahmad
Exact cause of primary dysmenorrhoea is unknown but recent evidence uncovers a potential link between gut dysbiosis and benign gynaecological disorder via disruption of estrobolome. A randomized controlled trial to investigate the effects of multi-strain oral probiotics HEXBIO MCP BCMC on primary dysmenorrhoea has been conducted. This is a secondary analysis comparing the stool microbiome in women with primary dysmenorrhoea and those without (control), and the effects of treatment with probiotics versus placebo. Although microbial richness and evenness were comparable between groups (alpha diversity, p > 0.05), gut microbial community composition differed significantly (Bray–Curtis PERMANOVA, p = 0.015), characterised by reduced Bifidobacterium adolescentis and Blautia and enrichment of Faecalibacterium in dysmenorrhoea, alongside condition-specific core taxa. Post-intervention analysis revealed significant shifts in microbial community structure between pre- and post-treatment groups (PERMANOVA, F = 1.5768, R² = 0.11071, p = 0.022), with probiotic supplementation inducing more consistent and directed microbiome changes than placebo, without altering alpha diversity (p > 0.05). Functional prediction showed no significant difference in overall β-glucuronidase pathway abundance (p > 0.05). This discovery provides distinct gut microbiome patterns and predicted functional changes, although further functional validation is required.